About us
Taiwan Genomic Industry Alliance inc. (TGIA) – A Taiwanese company located in Nankang Software Park as a business center, which was established under the guidance of the “Asia Pacific Biomedical Silicon Valley Precision Medicine Program ”operated by the National Health Research Institutes (NHRI) in 2017 and was approved to be officially stationed in the Hsinchu Biomedical Science Park as an operational headquarter and the R&D center in 2022. Through the collaboration and technical transfer from the NHRI, We anticipate to become the leading company in the field of disease, genetics and cancer genetics sequencing, and become an important medical hub in the Asia-Pacific region under the cooperation with the medical centers.
TGIA has build the most advanced next-generation and third generation high throughput industrial-grade sequencing laboratory in Taiwan, including Illumina NovaSeq X Plus, Illumina Novaseq 6000 and Pacbio Sequel IIe, capable of providing high quality sequencing service. Futhermore, Benefiting from NHRI’s technology transfer, as well as high-throughput sequencing equipment，we are able to build the database contain rare disease-related genetic variants, cancer variants, and phenotypes of Asians, which could vigorously promote the research and improve health outcomes, thereby, benefit for the precision medicine development.
To this day, TGIA remains committed to continuous improvement, developing high-quality, high detection rate, and affordable solutions. We are accelerating the widespread adoption of genetic testing for hereditary and rare diseases, while also focusing on precision medicine in various fields such as cancer, microbiology, and complex diseases. We anticipate to become the leading company in the field of disease, genetics and cancer genetics sequencing, and become an important medical hub in the Asia-Pacific region under the cooperation with the medical centers.
Vision and Mission
Our vision is to leading and working with strategic partners to establish a world-competitive Taiwan Gene Industry Alliance.
The company brings together important core skills such as laboratory animal technology, genetic testing and analysis, and genetic testing development and manufacturing processes, and will make every effort to provide high-quality biomedical products and services to realize the value of precision medicine in the Asia-Pacific region. With the goal of becoming a leader in domestic genomic testing services, we will develop an appropriate system to effectively apply genomic testing and analysis results to clinical medicine, implement precision medicine in the healthcare system, and realize the mission of precision medicine to improve human health.
Core Competence
Industrial laboratory integrates short and long reads
Medical Center Strategic Alliance
Bioinformatics supercomputing
AI driving interpertation
Asian Variant database
History
2017
Company Establishment
Nankang Software Park
2018
Industrial-Academia Collaboration Agreement with NHRI
Cooperate “Technology development and industry application for precision medicine” with NHRI
Entered the incubation center of NHRI
2018
2019
Setup Illumina NovaSeq 6000
2020
ISO/IEC 17025 Accreditation & Setup PacBio Sequel Ⅱe
ISO/IEC 17025 Accreditation
PacBio Sequel Ⅱe Service Launched
2020
2021
Business center R&D Center
Taipei Business center
R&D Center in Hsinchu Science Park
2023
EMQN Certified & Setup Illumina NovaSeq X Plus
EMQN Certified
Illumina NovaSeq X Plus Service Launched
2023